Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 15
1966 9
1967 13
1968 11
1969 29
1970 22
1971 22
1972 44
1973 50
1974 56
1975 57
1976 39
1977 53
1978 37
1979 62
1980 55
1981 69
1982 98
1983 93
1984 76
1985 109
1986 118
1987 133
1988 109
1989 138
1990 121
1991 112
1992 118
1993 130
1994 110
1995 141
1996 138
1997 135
1998 178
1999 148
2000 126
2001 131
2002 122
2003 118
2004 123
2005 119
2006 119
2007 131
2008 102
2009 80
2010 76
2011 111
2012 107
2013 100
2014 105
2015 113
2016 90
2017 74
2018 57
2019 68
2020 57
2021 66
2022 83
2023 73
2024 67
2025 64
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,148 results

Results by year

Filters applied: . Clear all
Page 1
A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
Roy SK, Islam A, Ali R, Islam KE, Khan RA, Ara SH, Saifuddin NM, Fuchs GJ. Roy SK, et al. Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):460-2. doi: 10.1016/s0035-9203(98)91094-x. Trans R Soc Trop Med Hyg. 1998. PMID: 9850410 Clinical Trial.
Ampicillin was chosen as additional therapy for acute respiratory tract infection, present in many subjects with diarrhoea. ...Compared to tetracycline, the clinical recovery rates by 96 h were 75% with placebo, 91.3% with ampicillin, and 95.7% with eythromycin. Com …
Ampicillin was chosen as additional therapy for acute respiratory tract infection, present in many subjects with diarrhoea. ...Compar …
[Bacampicillin].
Mashimo K. Mashimo K. Jpn J Antibiot. 1982 Dec;35(12):2723-35. Jpn J Antibiot. 1982. PMID: 6763634 Review. Japanese. No abstract available.
A comparative randomized double-blind clinical trial of pivampicillin and ampicillin in lower respiratory tract infections.
Dewan J, Malik SK, Jindal SK, Sharma PL. Dewan J, et al. Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):85-7. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7037662 Clinical Trial.
The efficacy and safety of pivampicillin was compared with that of ampicillin in 52 patients suffering from lower respiratory tract infections. Equimolar doses of pivampicillin (350 mg) and ampicillin (250 mg) were administered three times daily for 15 days in ident …
The efficacy and safety of pivampicillin was compared with that of ampicillin in 52 patients suffering from lower respiratory tract i …
Treatment of typhoid.
Thiruvengadam KV, Subramanian N, Sharma AV, Krishnaswamy S, Nalini S. Thiruvengadam KV, et al. Br Med J. 1973 Mar 10;1(5853):612. doi: 10.1136/bmj.1.5853.612. Br Med J. 1973. PMID: 4571670 Free PMC article. Clinical Trial. No abstract available.
Pharmacological and clinical study of bacampicillin in acute peritonsillitis--a comparison with ampicillin.
Hallander HO, Flodström A, Sjövall J. Hallander HO, et al. Antimicrob Agents Chemother. 1977 Feb;11(2):185-90. doi: 10.1128/AAC.11.2.185. Antimicrob Agents Chemother. 1977. PMID: 322607 Free PMC article. Clinical Trial.
The pharmacological and clinical properties of bacampicillin in three dosage groups were studied in 66 hospitalized patients with unilateral acute peritonsillitis in a comparison with ampicillin. Bacampicillin is a new semisynthetic aminopenicillin which is rapidly convert …
The pharmacological and clinical properties of bacampicillin in three dosage groups were studied in 66 hospitalized patients with unilateral …
A comparative trial of doxycycline and ampicillin in the treatment of acute sinusitis.
Agbim OG. Agbim OG. Chemotherapy. 1975;21 Suppl 1:68-75. doi: 10.1159/000221893. Chemotherapy. 1975. PMID: 1098875 Clinical Trial.
A double-blind comparative clinical trial of doxycycline (200 mg on the first day followed by 100 mg daily for a total of 7 days) and ampicillin (250 mg 4 times daily for 7 days) was performed in 44 patients with acute or chonic sinusitis. Significantly superior results we …
A double-blind comparative clinical trial of doxycycline (200 mg on the first day followed by 100 mg daily for a total of 7 days) and amp …
Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
Güneren MF. Güneren MF. Drugs. 1988;35 Suppl 7:57-68. doi: 10.2165/00003495-198800357-00014. Drugs. 1988. PMID: 3065055 Clinical Trial.
Standard doses of sulbactam/ampicillin (0.25/0.5 g) were administered intramuscularly bid for 4 to 15 days (mean 7.5 days). ...Persistence of pathogens was observed in 4.6%, and eradication with development of a superinfection in 4.1%. In vitro superiority of sulbactam/ …
Standard doses of sulbactam/ampicillin (0.25/0.5 g) were administered intramuscularly bid for 4 to 15 days (mean 7.5 days). ...Persis …
[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology].
Vergnon JM, Vincent M, Ros A, Brun Y, Brune J. Vergnon JM, et al. Rev Pneumol Clin. 1985;41(3):205-11. Rev Pneumol Clin. 1985. PMID: 4048752 Clinical Trial. French.
Cefoperazone was prescribed in 2 infusions per 24 hours. Ampicillin was given as 3 infusions, followed by tobramycin administered by a similar number of injections. The duration of treatment was 16.8 +/- 9 days (cefoperazone) and 11,8 +/- 6,5 days (ampicillin + tobr …
Cefoperazone was prescribed in 2 infusions per 24 hours. Ampicillin was given as 3 infusions, followed by tobramycin administered by …
Bioequivalence study of sultamicillin suspensions.
Sailer R, Arnold P, Erenmemişoğlu A, Martin W, Tamur U, Kanzik I, Hincal AA. Sailer R, et al. Arzneimittelforschung. 2007;57(4):232-7. doi: 10.1055/s-0031-1296610. Arzneimittelforschung. 2007. PMID: 17515294 Clinical Trial.
The median t(max) was 0.69 h (ampicillin, test), 0.85 h (ampicillin, reference), 0.72 h (sulbactam, Devasid) and 0.83 h (sulbactam, reference). Plasma elimination half-lives (t(1/2)) of 1.04 h (ampicillin, test), 1.03 h (ampicillin, reference), 1.26 h …
The median t(max) was 0.69 h (ampicillin, test), 0.85 h (ampicillin, reference), 0.72 h (sulbactam, Devasid) and 0.83 h (sulba …
5,148 results